These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10576408)

  • 1. Approximate sample sizes for testing hypotheses about the ratio and difference of two means.
    Kieser M; Hauschke D
    J Biopharm Stat; 1999 Nov; 9(4):641-50. PubMed ID: 10576408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for a three-arm equivalence trial of normally distributed responses.
    Chang YW; Tsong Y; Dong X; Zhao Z
    J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical equivalence.
    Bristol DR
    J Biopharm Stat; 1999 Nov; 9(4):549-61. PubMed ID: 10576403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalence and superiority testing in regeneration clinical trials.
    Gunsolley JC; Elswick RK; Davenport JM
    J Periodontol; 1998 May; 69(5):521-7. PubMed ID: 9623894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size determination for equivalence test using rate ratio of sensitivity and specificity in paired sample data.
    Lui KJ; Cumberland WG
    Control Clin Trials; 2001 Aug; 22(4):373-89. PubMed ID: 11514039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
    Vavken P
    Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
    Koti KM
    J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
    Röhmel J; Hauschke D
    Biom J; 2006 Feb; 48(1):174-5; author reply 176. PubMed ID: 16544822
    [No Abstract]   [Full Text] [Related]  

  • 9. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and analysis of a 3-arm noninferiority trial with a prespecified margin for the hazard ratio.
    Hida E; Tango T
    Pharm Stat; 2018 Sep; 17(5):489-503. PubMed ID: 29984524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On sample size calculation for 2x2 fixed-effect ANOVA when variances are unknown and possibly unequal.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):417-25. PubMed ID: 18559139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning and analysis of three-arm non-inferiority trials with binary endpoints.
    Kieser M; Friede T
    Stat Med; 2007 Jan; 26(2):253-73. PubMed ID: 16685703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designs of superiority and noninferiority trials for binary responses are noninterchangeable.
    Hilton JF
    Biom J; 2006 Dec; 48(6):934-47. PubMed ID: 17240653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approximate approach to sampling size determination for the equivalence hypothesis.
    Hsieh CY; Liu JP
    J Biopharm Stat; 2013 May; 23(3):526-38. PubMed ID: 23611193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the response rates for superiority, noninferiority and equivalence testing with multiple-to-one matched binary data.
    Tsong Y; Yuan M; Dong X; Wu YT; Shen M
    J Biopharm Stat; 2013; 23(1):98-109. PubMed ID: 23331224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size determination: extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43.
    Diletti E; Hauschke D; Steinijans VW
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S59-62. PubMed ID: 1601533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.